SCHEMBL8437527

SCHEMBL8437527

Cc1cnccc1Nn1c(C)cc2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.65
TOP2A P11388 1/20 0.35
PDE10A Q9Y233 2/20 0.35
PDE2A O00408 1/20 0.35
MAPT P10636 3/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
FGB P02675 1/20 0.34
POLB P06746 1/20 0.34
CYP17A1 P05093 1/20 0.33
CYP1A2 P05177 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
ATM Q13315 1/20 0.33
IMPDH2 P12268 1/20 0.32
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7609197 0.86 SLC6A2 (0.62) SLC6A2
SCHEMBL7610888 0.79 SLC6A2 (1.00) SLC6A2MAPTKMT2AMEN1KDM4E
SCHEMBL7609735 0.75 SLC6A2 (0.59) SLC6A2PDE10APDE2AMAPT
SCHEMBL8442016 0.70 SLC6A2 (0.67) SLC6A2TOP2APDE10APDE2ACYP17A1
SCHEMBL27677785 0.69 SLC6A2 (0.57) SLC6A2MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL24973496 0.66 SLC6A2 (0.54) SLC6A2MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL21803769 0.65 MAPT (0.53) SLC6A2TOP2APDE10APDE2AMAPT
SCHEMBL8440423 0.64 SLC6A2 (0.69) SLC6A2
SCHEMBL25919180 0.64 ALOX12 (0.47) SLC6A2MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL1630931 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4970218-A ANALGESIC, ANTIDEPRESSANT, MEMORY ENHANCEMENT HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-11-13 US claimed
EP-0635269-B1 Use of N-(Pyridinyl)-1H-Indol-1-Amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders HOECHST MARION ROUSSEL INC (US) 1999-11-03 EP disclosed
EP-0635269-A1 Use of N-(Pyridinyl)-1H-Indol-1-Amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-01-25 EP disclosed
US-5356910-A Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-10-18 US disclosed
US-5039811-A Analgesics, antidepressants, memory activators; condensation, reduction HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-08-13 US disclosed
US-4970218-A ANALGESIC, ANTIDEPRESSANT, MEMORY ENHANCEMENT HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-11-13 US disclosed